B. Braun Medical announced that it received FDA emergency use authorization to use its infusion pumps with nebulizers to treat patients with COVID-19.
The Bethlehem, Pa.-based company’s authorization win includes its Perfusor space syringe infusion pump, Infusomat space volumetric infusion pump and Outlook ES pump systems. The pumps can be used for tracheal delivery of continuous nebulized medications into a nebulizer with the intent of treating patients of all ages with or suspected of having coronavirus, while also decreasing the exposure of healthcare providers to the virus.
